Alagappan, Lakshmi Priyankka
Ramaswamy, Yazhini
Sundaramoorthy, Deepak Kumar
Bhaskar, Joshitha
Sarangapani, Sripriya
Sen, Parveen
Raman, Rajiv
Bhende, Muna
Mathavan, Sinnakaruppan
Funding for this research was provided by:
Bayer
Article History
Received: 9 April 2022
Revised: 16 September 2022
Accepted: 3 October 2022
First Online: 12 October 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Vision Research Foundation, Sankara Nethralaya Hospital Review Board (IRB Ethics Approval Number -Study code: 636–2017-P) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Name of the institute (IRB) that approved the study: Vision Research Foundation, Sankara Nethralya Hospital, Chennai.
: Human subjects (patients) were used for this study and patient recruitment was done in the vitreoretinal clinic of Sankara Nethralaya (Chennai-India) after obtaining informed consent from all the patients and controls to obtain 8 ml of blood sample.
: The authors declare no competing interests.